Focused Investors LLC Acquires 90,100 Shares of UnitedHealth Group Incorporated $UNH

Focused Investors LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 21.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 504,000 shares of the healthcare conglomerate’s stock after purchasing an additional 90,100 shares during the quarter. UnitedHealth Group comprises 5.1% of Focused Investors LLC’s investment portfolio, making the stock its 8th biggest position. Focused Investors LLC’s holdings in UnitedHealth Group were worth $157,233,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter worth $42,000. Kentucky Trust Co lifted its stake in shares of UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after acquiring an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Barclays raised their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. KeyCorp dropped their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Finally, Truist Financial raised their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $365.00.

UnitedHealth Group Trading Up 1.4%

Shares of UNH stock opened at $363.95 on Wednesday. The stock has a market cap of $329.62 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm’s 50 day moving average price is $311.44 and its two-hundred day moving average price is $352.42.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the firm earned $6.80 earnings per share. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.